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Abstract
Urinary exosomes have been proposed as potential diagnostic tools. TNF superfamily cytokines and receptors may be
present in exosomes and are expressed by proximal tubular cells. We have now studied the expression of selected TNF
superfamily proteins in exosome-like vesicles from cultured human proximal tubular cells and human urine and have
identified additional proteins in these vesicles by LC-MS/MS proteomics. Human proximal tubular cells constitutively
released exosome-like vesicles that did not contain the TNF superfamily cytokines TRAIL or TWEAK. However, exosome-like
vesicles contained osteoprotegerin (OPG), a TNF receptor superfamily protein, as assessed by Western blot, ELISA or
selected reaction monitoring by nLC-(QQQ)MS/MS. Twenty-one additional proteins were identified in tubular cell exosome-
like vesicles, including one (vitamin D binding protein) that had not been previously reported in exosome-like vesicles.
Twelve were extracellular matrix proteins, including the basement membrane proteins type IV collagen, nidogen-1, agrin
and fibulin-1. Urine from chronic kidney disease patients contained a higher amount of exosomal protein and exosomal
OPG than urine from healthy volunteers. Specifically OPG was increased in autosomal dominant polycystic kidney disease
urinary exosome-like vesicles and expressed by cystic epithelium in vivo. In conclusion, OPG is present in exosome-like
vesicles secreted by proximal tubular epithelial cells and isolated from Chronic Kidney Disease urine.
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Introduction
Exosomes are small-sized nanovesicles originated inside the cell
traffic network and secreted through the fusion of multivesicular
bodies with the cell membrane [1,2]. Exosomes and other
microvesicles are found in most human fluids, including human
urine, and are secreted by a wide range of cell types [3,4]. Urinary
exosomes have obtained wide attention regarding their potential
role as disease biomarkers [5,6,7]. However, very little is known
about exosome secretion by kidney cells, the composition of kidney
cell exosomes or their function.
Unraveling the function of exosomes holds promise to develop
new therapeutic approaches to human disease. Potential biological
functions of exosomes include antigen presentation and regulation
of programmed cell death, angiogenesis, inflammation and
coagulation [3,8]. Exosomes may carry morphogens, chemo-
attractant signals, miRNAs and mRNAs [9]. T cell exosomes
contain members of the TNF superfamily of proapoptotic
cytokines such as TRAIL, TNF and FasL and their presence in
exosomes is key to death of T cell target cells [10,11]. In this
regard, TNF superfamily proteins are often more lethal if
anchored to a membrane surface than in solution [12]. Further-
more, members of the TNF receptor superfamily may also be
present in exosomes. Microvesicles containing TNF-R1 function
as decoys for TNF signaling [13]. Tubular cells express functional
TNF superfamily proapoptotic cytokines such as TNF, Fas ligand,
TRAIL and TWEAK [14,15,16,17,18]. Emphasizing the potential
importance of these cytokines for kidney pathophysiology, a
human kidney transcriptomics approach disclosed that TRAIL
and its decoy receptor osteoprotegerin (OPG/OCIF/
TNFRSF11B) [19] were the apoptosis-related genes most highly
expressed in diabetic nephropathy (DN), the most frequent form of
chronic kidney disease (CKD) [16]. Immunohistochemistry
disclosed that tubular cells were the main source of TRAIL in
DN [16]. In culture, there was functional evidence for the
expression of OPG by tubular cells [16]. OPG is a TNF receptor
superfamily glycoprotein of 401 amino acids, frequently attached
to various proteoglycans [20], [21]. OPG was initially described as
a decoy receptor for receptor activator of NFkB ligand (RANKL)
that regulates osteoclastogenesis [20]. Serum levels of OPG are
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increased in CKD patients and have been associated with vascular
calcification [22].
We have now addressed the composition of tubular cell-derived
exosome-like vesicles by two complementary approaches. First, we
explored the presence in human proximal tubular cell-derived
exosome-like vesicles of selected TNF superfamily proteins and
receptors. Specifically we focused on those most highly expressed
in DN, TRAIL and OPG. In addition, we employed a proteomics
approach to identify additional components of tubular epithelial
cell exosome-like vesicles that might shed light onto their function.
We did not find TRAIL in proximal tubular cell exosome-like
vesicles. Surprisingly, OPG was identified as a tubular cell
exosomal protein by a variety of techniques. We also show for
the first time that exosomal OPG is increased in urinary exosome-
like vesicles from CKD patients.
Materials and Methods
Cell Culture
HK-2 human proximal tubular epithelial cells (ATCC, Rock-
ville, MD) were grown on RPMI 1640 (GIBCO, Grand Island,
NY), 10% heat-inactivated fetal bovine serum, 2 mM glutamine,
100 U/mL penicillin, 100 mg/mL streptomycin, 5 mg/mL insulin,
5 mg/mL transferrin, 5 ng/mL sodium selenite, and 5 ng/mL
hydrocortisone in 5% CO2 at 37uC as previously described [23].
For experiments cells were rested in serum-free media for 24 h
prior to sample collection.
Clinical Characteristics of Patients
Second morning void urine samples were obtained from human
healthy volunteers or stable CKD patients who donated urine
samples. All the study ‘‘OPG in exosome-like vesicles from human
cultured tubular cells and urine’’, and the human samples used,
has been approved by the IIS-Fundacion Jimenez Diaz Biobank
Local Ethics Biobank. Informed consent were signed by all the
patients involved in the study, and all clinical investigation were
conducted according to the principles expressed in the Declaration
of Helsinki. Clinical characteristics are summarized in Table 1.
The eGFR was estimated from serum creatinine using the
Modification of Diet in Renal Disease (MDRD) Study Group
equation: eGFR (ml/min/1.73 m2) = 1866(SCr)21.1546(age in
years)20.2036(0.742, if patient is female)6(1.212, if patient
ethnicity is black) [24]. Healthy controls were 3 males and one
female, 61610-year-old, non-diabetics, with serum creatinine
,1.2 mg/dl and albuminuria ,30 mg/g creatinine. A cocktail of
protease inhibitors (2 mM AEBSF, 0.3 mM aprotinin, 130 mM
bestatin, 1 mM EDTA, 14 mM E-64, 1 mM leupeptin, Sigma-
Aldrich) were added to 100 ml urine and samples were frozen at
280uC until microvesicle extraction.
Microvesicle Isolation
Microvesicles were obtained by serial ultracentrifugation at 4uC.
In each centrifugation the pellet was discarded and the superna-
tant used in the next step. The first steps eliminate dead cells and
large cell debris [25]. For cell culture supernatants, we normalized
the values to 1 ml of culture medium conditioned per million cells.
The yield was 12516349.95 ng of exosomal protein/million cells.
The isolation starts with a 3006g (cells and cell debris removal)
centrifugation for 10 minutes; 1,1006g for 10 minutes twice;
6,0006g for 10 minutes; 17,0006g for 30 minutes and 200,0006g
for 70 minutes. This last step precipitates small particles
corresponding to exosome-like vesicles secreted into the culture
medium. This pellet was washed with a large volume of PBS to
avoid contamination with soluble proteins and then centrifuged
again for 70 minutes at 200,0006g. The final pellet obtained was
resuspended in various solvents (PBS, lysis buffer), depending on
the purpose of the extraction. For urine samples we followed a
modified protocol, optimized for urine. After thawing the 50–
100 ml samples, an aliquot was removed and whole urine was
centrifuged at 17,0006g for 30 minutes. The pellet was
resuspended in isolation buffer (200 mM sucrose, 10 mM trieth-
anolamine) and dithiothreitol (DTT) was added (200 mg/ml) to
disrupt Tamm-Horsfall protein network that entraps exosome-like
vesicles, thus increasing isolation efficiency [4,26]. After adding
Table 1. Clinical characteristics.
Gender Age (years) DM Cause of CKD sCr (mg/dl) eGFR (ml/min) UProt (mg/dl)
M 46 Yes DN 3.8 18 32
M 83 Yes DN 2.9 22 130
M 79 Yes DN 1.6 13 296
M 69 No GN 6 5 185
F 50 No CAKUT 3.5 15 38
M 55 No ADPKD 4.6 14 86
M 68 No ADPKD 6.7 9 196
M 29 No ADPKD 1.2 81 13
M 65 No ADPKD 2.4 29 6
F 74 No ADPKD 3.2 15 47
M 53 No ADPKD 6.2 8 47
M 65 No ADPKD 1.4 54 4
F 62 No ADPKD 2.3 23 4
F 76 No ADPKD 5.4 8 17
Summary data 62615 3.6661.86 22621 79690
Summary data expressed as mean6SD.
sCr: serum creatinine, eGFR: estimated glomerular filtration rate, UProt: urinary protein.
doi:10.1371/journal.pone.0072387.t001
OPG in Renal Urinary Exosome-Like Vesicles
PLOS ONE | www.plosone.org 2 August 2013 | Volume 8 | Issue 8 | e72387
DTT, the solution was centrifuged again at 17,0006g for 10
minutes, the pellet containing precipitated Tamm-Horsfall protein
was discarded and the supernatant containing exosome-like
vesicles was mixed with the first centrifugation supernatant kept
at 4uC. The newly reconstituted samples were centrifuged at
200,0006g for 70 minutes at 4uC. The pellet obtained was
resuspended in PBS or lysis buffer as required. Exosomal protein
was assessed by the Bradford assay. All centrifugations were
performed following described standard procedures [27], using a
70 Ti fixed angle rotor with 26 ml polycarbonate tubes. Conver-
sion from rpms to RFCs (Relative Centrifugal Force; gs) were
made automatically by the centrifuge.
ELISA
OPG was quantified by ELISA (Biomedica Gruppe) following
the manufacturer instructions. Proteins from the following origins
were assayed: tubular epithelial cells, whole human urine, tubular
cell culture supernatant, tubular cell derived exosome-like vesicle
and urinary exosome-like vesicles. Optical density (OD) was read
in all wells on a plate reader using 450 nm wavelength (correction
wavelength 630 nm). We construct the standard curve from the
OD values of an OPG standard with a range 0 to 20 pmol/l and
obtained the sample concentration from this standard curve. The
detection limit of the assay is 0.07 pmol/l.
Transmission Electron Microscopy
The pellet containing exosome-like vesicles was resuspended in
2% paraformaldehyde/PBS, and 5 ml were plated on Formvar/
carbon-coated grids (Ted Pella Inc. CA, USA). After adsorption,
grids were washed several times in PBS and transferred to 1.5%
glutaraldehyde for 5 minutes. After another series of washes, grids
were transferred to a uranyl-oxalate solution for 5 minutes and to
methylcellulose-uranyl-oxalate for 10 minutes. Grids were dried
and observed in a transmission electron microscope at 80 kV.
Flow Cytometry
Because of their small size, exosomes can only be analyzed in a
flow cytometer after linkage to larger particles of known size.
Exosome-like vesicles were adsorbed to solid 3.9 mm latex
microspheres composed of aldehyde-free sulfate surfactants
(Interfacial Dynamics, USA). Microspheres/exosomes were incu-
bated with anti-CD63-PE antibody (Becton-Dickinson) and
analyzed on a FACScalibur flow cytometer (Becton-Dickinson).
Table 2. Proteins identified in tubular epithelial cell-derived exosomes by SDS-PAGE and LC-MS/MS analysis.
Gene Protein UniProtKB/Swiss-Prot Conf. (%) Exocarta
AGRN Agrin Junction formation and maintenance.
Basement membrane. ECM
99 Y
ACTBL2 Beta-actin-like protein 2 Cell motility 99 Y
C3 Complement C3 Activation of the complement system.
Innate immunity
99 Y
CHRDL1 Chordin-like protein 1 Antagonizes the function of BMP4
(Bone morphogenic protein)
99 Y
COL4A1 Collagen alpha-1 (IV) chain Structural component of glomerular
basement membranes. ECM
99 Y
COL4A2 Collagen alpha-2(IV) chain Basement membrane. ECM 99 Y
LGALS3BP Galectin-3-binding protein Promotes integrin-mediated cell adhesion. ECM 99 Y
FBLN1 Fibulin-1 Role in cell adhesion and migration.
Basement membrane. ECM
99 Y
FN1 Fibronectin Involved in cell adhesion and migration. ECM 99 Y
THBS1 Thrombospondin-1 Cell-to-cell and cell-to-matrix interactions.
Binds heparin. ECM
99 Y
TINAGL1 Tubulointerstitial nephritis antigen-like Non-catalytic peptidase C1 family protein 99 Y
TGFBI TGF-b-induced protein ig-h3 Cell-collagen interactions. ECM 99 Y
CYR61 Protein CYR61 Proliferation, chemotaxis,
angiogenesis and cell adhesion. ECM
98 Y
HSPA4L Heat shock 70 kDa protein 4L Chaperone activity 98 Y
PKM Pyruvate kinase, muscle Glycolytic enzyme involved in ATP generation 98 Y
SRBD1 S1 RNA-binding domain-containing protein 1 Nucleobase-containing compound. RNA binding. 97 Y
VCP Valosin containing protein Involved in the formation of
the transitional endoplasmic reticulum
96 Y
PXDN Peroxidasin homolog Peroxidase activity. ECM 95 Y
GC Vitamin D-binding protein Multifunctional protein found in biological fluids 92 N
LAMA5 Laminin subunit alpha-5 Cell migration. Basement membrane. ECM 92 Y
NID1 Nidogen-1 Basement membrane. ECM 92 Y
Exocarta: Presence (Y) or absence (N) in the exosomal database Exocarta, accessed December 28, 2012. [37]. In addition several keratins were identified (Table S1).
Conf.: confidence of the identification. ECM: extracellular matrix.
doi:10.1371/journal.pone.0072387.t002
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Western Blot
Western blots were performed as previously described [28].
Membranes were incubated overnight at 4uC with anti-OPG
antibody (1:500, Acris Antibodies GmbH, Germany), anti-TRAIL
(1:1,000, R&D systems), anti-ALIX (1:1000; Santa Cruz Biotech-
nology, CA, USA), anti-TSG101 (1:1000; AbCam, Boston, MA,
USA), anti-CD63 (1:2000; Millipore, MA, USA), anti-Calnexin
(Calbiochem), anti-Tweak (1:500, Santa Cruz Biotechnology),
anti-Fibronectin (1:1000, Millipore, MA, USA), anti-C3 (kind gift
from Dr. Pastor-Vargas) and anti-TGFb-iH3 (1:1000, Santa Cruz
Biotechnology, CA, USA) followed by incubation with horseradish
peroxidase-conjugated secondary antibody (1:2,000, Amersham,
Aylesbury, UK). The use of a different anti-OPG antibody (Santa
Cruz) yielded results similar to those shown in the figures. Blots
were developed with the enhanced chemiluminescence method
(ECL) following the manufacturer’s instructions (Amersham). All
assays were performed under reducing conditions (adding b-
mercaptoethanol as reducing agent into the loading buffer) except
for CD63. Autoradiographs were scanned using the GS-800
Calibrated Densitometer (Quantity One, Bio-Rad).
Sample Preparation for LC-MS/MS
Exosomal protein extract (50 mg) from tubular epithelial cell
supernantants was concentrated and desalted. In a first attempt
electrophoresis was performed until the sample passed through the
stacking gel and reached the running gel. At that moment,
electrophoresis was stopped and the gel was stained using colloidal
Coomassie (Fermentas). The piece of stained gel in which the
sample was concentrated was excised and digested. In this way, all
proteins were concentrated in a unique band, eliminating sample
contaminants [29]. To further increase the number of identified
proteins, full electrophoresis was additionally performed and the
Figure 1. Characterization of exosomal-like vesicles isolated by serial centrifugation from cultured human proximal tubular
epithelial cells. Microvesicles from tubular cell conditioned serum-free media present exosomal features. A) Transmission electron microscopy
shows vesicles have a diameter 50–100 nm, consistent with exosomes. i) Scale bar = 200 nm, ii) Scale bar = 100 nm, iii & iv) Scale bar = 50 nm. Arrows
point to exosomes. B) Representative Western blot for the exosome marker CD63. Each lane contains 20 mg protein obtained from the pellet of the
following sequential centrifugation steps: P1 1,1006g, P2 1,1006g, P3 6,0006g, P4 17,0006g, and P5 100,0006g supernatant. Exo: exosomes present
in the 200,0006g pellet. C) Standard exosome markers were present in exosomes secreted by HK2 cells (Western blot). Each lane contains 6 mg of
exosomal proteins. D) CD63 expression assessed by latex bead flow cytometry. Black peak: control beads. White peak: beads+PE–conjugated anti-
CD63. Grey peak: beads+PE–conjugated anti-CD63+5 mg exosomes. FLH3: fluorescence intensity.
doi:10.1371/journal.pone.0072387.g001
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stained gel pieces were excised. Digestion was performed
according to Schevchenko et al [30] with minor modifications:
the gel piece was incubated with 10 mM DTT in 50 mM
ammonium bicarbonate (99% purity; Scharlau) for 30 min at
56uC and after reduction, alkylated with 55 mM iodoacetamide
(Sigma Aldrich) in 50 mM ammonium bicarbonate for 20 min at
RT. Gel plugs were washed with 50 mM ammonium bicarbonate
in 50% methanol (gradient, HPLC grade, Scharlau), rinsed in
acetonitrile (gradient, HPLC grade, Scharlau) and dried in a
Speedvac. Dry gel pieces were then embedded in sequencing
grade modified porcine trypsin (Promega, Madison, WI, USA) at a
final concentration of 20 ng/mL in 20 mM ammonium bicarbon-
ate. After digestion at 37uC overnight, peptides were extracted
with 60% acetonitrile (ACN) in 0.1% formic acid (99.5% purity;
Sigma Aldrich) and the sample were resuspended in 98% water
with 2% formic acid (FA) and 2% ACN.
LC-MS/MS and Database Searching
The LC/MSMS system consisted of a TEMPO nano LC
system (Applied Biosystems) combined with a nano LC Auto-
sampler. LC-MS/MS analysis was performed on an AB/MDS
Sciex 4000 Q TRAP System with NanoSprayII Source (Applied
Biosystems). Two replicate injections (4.5 mL) were made for each
sample using mobile phase A (2% ACN/98% water, 0.1% FA)
with a flow rate of 10 mL/min for 5 min. Peptides were loaded
onto a m-Precolumn Cartridge (Acclaim Pep Map 100 C18, 5 mm,
100 A˚; 300 mm i.d. X 5 mm, LC Packings) to preconcentrate and
desalt samples. RPLC was achieved on a C18 column (Onyx
Figure 2. Proximal tubular cell exosomes contain OPG. A) Exosomes from HK-2 conditioned serum-free cell culture media. Representative
Western blots of TRAIL, TWEAK and exosome markers. Each lane contains 5 mg exosomal protein. B) OPG is observed in HK-2-derived exosomes when
reducing, denaturizing conditions are applied. Each lane contains 10 mg exosomal protein. C) OPG expression in HK-2-derived exosomes detected by
ELISA. Results expressed as pg/mg of total protein. Mean+SEM of 3 independent experiments. D) OPG analysis by selected reaction monitoring (SRM)
in a LC-(QQQ)-MS/MS showing two different transitions corresponding to the same precursor peptide which coelute in time. The mass and charge of
the precursor and its fragments are shown. A single peptide (YLHYDEETSHQLL) and a single precursor were measured under two different charge
state (1025.9624+2 and 684.3107+3), each of them with its own fragment (1230.5783+ and 1138.4687+, respectively), thus yielding two different
peaks or transitions.
doi:10.1371/journal.pone.0072387.g002
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Monolithic C18 15060.1 mm, Phenomenex) using mobile phase
A (2% ACN/98% water, 0.1% FA) and mobile phase B (98%
ACN/2% water, 0.1% FA). Peptides were eluted at a flow rate of
300 nL/min by the following gradient: initial conditions 5% B,
increased to 40% B over 40 min, 40 to 95% B for 1 min and then
95% B for 4 min, returning next to initial conditions (5% B) in
2 min and maintaining them for 14 more minutes.
The TEMPO nano LC system and 4000 QTRAP were both
controlled by Analyst Software v.1.5.1. Analyst software creates
wiff format files including all the spectra data. Wiff files were
batch-processed by ProteinPilotTM Software 2.0.1 (Applied
Biosystems/MDS Sciex) which automatically generated peak lists
that were searched against the Swissprot database version 2011_01
using MASCOT version 2.2 (Matrix Science) [31], with 0.8 Da
precursor and MS/MS fragment tolerance, allowing 1 missed
cleavage and setting carbamidomethyl cysteines and methionine
oxidation as modifications.
All the MS and MS/MS data were achieved in positive ion
mode with an ion spray voltage of 2800 V, a declustering potential
of 80 V and a nanoflow interface temperature of 150uC. Nitrogen
was applied as both curtain and collision gas, setting source gas 1
and curtain gas to 20 psi. An Information Dependent Acquisition
(IDA) method was programmed, with a full scan Enhanced MS
(EMS) experiment at 4000 amu/s for ion profiling, followed by an
enhanced resolution (ER) MS experiment at 250 amu/s. ER
experiment allowed charge state recognition, further used by the
IDA criteria to select precursor ions and to estimate the collision
energy to fragment them. This IDA criteria was set to select the 8
doubled, tripled or quadrupled charged most intense ions from
400–1200 m/z that exceed 100,000 counts for fragmentation in
the LINAC collision cell, excluding isotopes within a 4.0 amu
window and with a mass tolerance of 1000,000 mmu. These
8 ions were submitted to 8 independent Enhanced Product Ion
(EPI) MS/MS experiments at 4,000 amu/s with Dynamic Fill
Time (DFT). The total number of MS and MS/MS experiments
per cycle was 10 (1 EMS, 1 ER and 8 EPI), resulting in a total
cycle time of 5.0058 s.
OPG Analysis by Selected Reaction Monitoring (SRM) in a
QQQ-LC/MS
SRM was performed to specifically identify OPG in exosome-
like vesicles. Exosome-like vesicles were lysed in 7 M urea, 2 M
thiourea and 4% Chaps and proteins were precipitated in acetone
and solved in 8 M urea, reduced with 10 mM DTT (Sigma
Aldrich) for 30 min at 37uC and alkylated for 20 min at room
temperature with 55 mM iodoacetamide (Sigma Aldrich). Proteins
were then digested in 50 mM ammonium bicarbonate (pH 8.5),
with sequencing grade modified bovine trypsin (Merck) at a final
concentration of 1:50 (trypsin:protein). After overnight digestion at
37uC, 1 ml trifluoroacetic acid (Merck) was added to stop the
reaction and tryptic peptide solutions were cleaned with C18 spin
columns (Protea Biosciences) according to the manufacturer’s
instructions. Tryptic digests were dried in a Speedvac and
resuspended in mobile phase A (5% acetonitrile (Merck), 0.1%
Figure 3. Relationships between OPG and proteins identified in tubular cell-derived exosomal-like vesicles by LC-MS/MS as
evidenced by the STRING database. STRING map of predicted associations for the sub-set of proteins compiled in Table 2. The network nodes
are proteins and the edges represent the predicted functional associations based on evidence which are represented by different color lines: green
line, neighborhood in the genome; blue line, co-occurrence across genomes; purple line, experimental evidence; yellow line, text mining evidence;
light blue line, database evidence; black line, co-expression evidence. The highest confidence filter was applied. NID1: Nidogen 1; COL4A1/2: Colagen
4 A1/2; THBS1: Thrombospondin-1; FBLN1: Fibulin 1, FN1: Fibronectin, TNFRSF11B: Osteoprotegerin; LGALS3BP: Galectin-3 Binding Protein, TGFBI:
TGF-b-induced protein ig-h3, GC: Vitamin D-binding protein; C3: Complement C3.
doi:10.1371/journal.pone.0072387.g003
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formic acid (Fluka)). Samples were analyzed in Selected Reaction
Monitoring (SRM) mode using a 6460 Triple Quadrupole LC/
MS/MS on-line connected to an nLC-ChipCube interface
(Agilent Technologies) and 1200 Series LC Modules (Agilent
Technologies) provided with a pre-cooled nLC autosampler.
The following is the FASTA sequence for OPG, where the 4
measured peptides are in bold and underlined:
MNNLLCCALVFLDISIKWTTQETFPPKYLHY-
DEETSHQLLCDKCPPGTYLKQHCTAKWKT
VCAPCPDHYYTDSWHTSDECLYCSPVCKELQYVK-
QECNRTHNRVCECKEGRYLEIEFCLK
HRSCPPGFGVVQAGTPERNTVCKRCPDGFFSNETSS-
KAPCRKHTNCSVFGLLLTQKGNAT
HDNICSGNSESTQKCGIDVTLCEEAFFR-
FAVPTKFTPNWLSVLVDNLPGTKVNAESVERI
KRQHSSQEQTFQLLKLWKHQNKDQDIVKKIIQDIDL-
CENSVQRHIGHANLTFEQLRSLME
SLPGKKVGAEDIEKTIKACKPSDQILKLLSL-
WRIKNGDQDTLKGLMHALKHSKTYHFPKT
VTQSLKKTIRFLHSFTMYKLYQKLFLEMIGNQVQSV-
KISCL
Peptide separation was carried out onto a ProtID chip with
4360.075-mm analytical column and 40 nL enrichment column
(Agilent Technologies). Samples were injected at 4 mL/min and
separation took place at 0.8 mL/min in a continuous acetonitrile
gradient: 5–30% B at 0.5 min, 30–99% B at 1 min and 99% B at
3.5 min (phase B: 100% acetonitrile, 0.1% formic acid). Mass
Hunter Software (v4.0) (Agilent Technologies) controlled the
system. The mass spectrometer was operated in positive ion mode
with capillary voltage of 1950 V, 325uC source gas temperature
and 5 L/min source gas flow. Fragmentor was set to 130 V, dwell
time to 250 ms, delta EMV to 200 V and collision energy was
optimized for each SRM transition. SRM methodology allows
specific detection of OPG proteotypic peptides. Theoretical SRM
transitions were designed using Skyline (v.1.1.0.2905) [32] and
manually inspected. OPG specificity was confirmed by protein
blast and prototypic peptides were selected for SRM analysis.
OPG Immunohistochemistry
The site of OPG protein expression in the kidney cortex was
localized by immunohistochemistry in 4 nephrectomy specimens
from non-diabetic patients obtained from the IIS-Fundacion
Jimenez Diaz biobank: A sample with preserved kidney histology
from a 76-year-old male suffering from kidney cancer with serum
creatinine 0.9 mg/dl and estimated glomerular filtration rate
(eGFR).60 ml/min; another kidney from a 74-year-old male had
histological features of CKD secondary to ureteral obstruction by
urothelial cancer, with serum creatinine 1.6 mg/dl and eGFR
45 ml/min. In addition 10 renal cysts from 2 autosomal dominant
polycystic kidney disease (ADPKD) patients on dialysis, male and
female, 54- and 62-year-old were studied. Paraffin-embedded
sections 5 mm thick were processed as described [23] and antigen
retrieval was performed at pH 9 (Dako). The primary antibody
was polyclonal rabbit anti-human OPG (1:500; Acris) and
secondary antibody was HRP-conjugated. Sections were counter-
stained with Carazzi`s hematoxylin. Negative controls included
incubation with a non-specific immunoglobulin of the same
isotype as the primary antibody.
Database Mining
In order to put the results in context and further define the
potential clinical and biological implications the sub-set of proteins
compiled in Table 2 was additionally analyzed by the following
databases, Kidney & Urinary Pathway Knowledge Base [33],
Figure 4. Exosomes from human urine contain OPG. A) Transmission electron microscopy representative images showing microvesicles
purified from human urine. i) Scale bar = 200 nm; ii) Scale bar = 50 nm; iii) Scale bar = 200 nm; iv)Scale bar = 50 nm. ii&iv) show amplified areas from
i&iii). B) Western blot. Representative images. Urine: whole urine collected from healthy donors. Supernat.: Urine supernatant from the last exosome
isolation step. 5 mg protein were loaded per well.
doi:10.1371/journal.pone.0072387.g004
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Nephromine [34] and STRING 9.0 software [35], consisting of a
database of known and predicted protein interactions, including
direct (physical) and indirect (functional) associations derived from
genomics, high-throughput experiments, coexpression and previ-
ous knowledge. The highest confidence (0.900) filter was applied.
Statistical Analysis
Results are expressed as mean 6 standard error of mean.
Differences between groups were assessed by the non-parametric
test Mann-Whitney test and p,0.05 was considered significant.
All the analysis was conducted using the SPSS statistical software
(version 11.0).
Results
Proximal Tubular Epithelial Cells Release Microvesicles
with Exosomal Features
Human proximal tubular HK2 cells constitutively release
microvesicles with exosomal features when cultured in serum-free
medium for 24 hours (Figure 1). Microvesicles were isolated
following a standard differential centrifugation exosome purifica-
tion protocol. Electron microscopy of the pellet obtained in the last
centrifugation showed that tubular epithelial cells secrete micro-
vesicles into the culture media. These vesicles were 50–100 nm in
diameter, consistent with previous descriptions of exosomes
(Figure 1A). To further characterize the purified vesicles as
exosomes, we studied common exosomal proteins using Western
blot and flow cytometry (Figure 1B–D). Pellets from the different
centrifugation steps were assayed by Western blot to assess the
exosomal tetraspanin CD63 (Figure 1C). Cells and dead cells/
debris express CD63. CD63 expression decreases through the
isolation process and is enriched in the final exosome-like vesicle
pellet. Microvesicles secreted by tubular cells were also positive for
Alix and TSG101 but calnexin was absent, indicating absence of
cytoplasmic contamination (Figure 1C). Flow cytometry confirmed
the presence of CD63 in exosomal vesicles from proximal tubular
cells (Figure 1D). These features indicate that human tubular
epithelial cells secrete exosome-like vesicles.
Tubular Epithelial Cell-derived Exosome-like Vesicles
Contain OPG but not TRAIL nor TWEAK
We have recently shown that cultured human tubular cells and
tubular cells from human CKD biopsies express TRAIL, and that
TRAIL promotes tubular cell death [16]. TRAIL is present in T
cell-derived exosomes [36] and membrane bound-TRAIL is more
lethal than soluble TRAIL. For these reasons we assessed the
presence of TRAIL in exosomes secreted by human proximal
tubular epithelial cells. However tubular epithelial cell-derived
exosome-like vesicles did not contain TRAIL nor TWEAK,
another TNF superfamily cytokine expressed by tubular cells
(Figure 2A). Interestingly, anti-OPG antibodies identified a band
of the expected size in Western blots run under reducing
conditions (Figure 2B). A second, different anti-OPG antibody
yielded similar results (not shown). The presence of OPG in
exosomes secreted by tubular epithelial cells was confirmed using a
specific ELISA assay for OPG (Figure 2C). We further confirmed
the presence of OPG in tubular epithelial cell-derived exosome-
like vesicles by selected reaction monitoring (SRM) in a QQQ-LC-
MS/MS (Agilent Technologies). The aim of the SRM was solely to
confirm specifically and unequivocally the presence of OPG in
those samples, confirming WB data. In particular, two different
transitions of the same precursor peptide could be detected co-
eluting in time (Figure 2D). Three additional peptides were
measured with several transitions per peptide (Figure S1).
Additional Proteins Present in Proximal Tubular Epithelial
Cell-derived Exosome-like Vesicles
Additional proteins present in exosome-like vesicles secreted by
proximal tubular epithelial cells were identified by proteomic
profiling. Exosomal protein extracts were concentrated and
desalted by SDS-PAGE and identified by LC-MS/MS (Table
S1). Twenty-one proteins were identified with a confidence
$90%. Neither canonical exosomal markers nor OPG were
identified by LC-MS/MS (Table 2). Most of the identified proteins
had already been described in exosome-like vesicles as assessed by
Exocarta [37]. However, this is the first time that vitamin D
Figure 5. OPG in human urinary exosomes. A) Urinary exosomal
protein content is higher in CKD patients (n = 14) than in healthy
volunteers (n = 4), * p = 0.042. B) Representative Western blot. 5 mg
urinary exosomal protein were loaded. All CKD samples in this blot
correspond to ADPKD patients. C) Quantification of OPG levels as
assessed by Western blot in ADPKD CKD patients (n = 9) and healthy
volunteers (n = 4). Results presented as mean+SEM, * p = 0.0476. A.D.U.
doi:10.1371/journal.pone.0072387.g005
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binding protein is described in exosome-like vesicles. Extracellular
matrix proteins and, specifically, basement membrane proteins
were overrepresented in tubular cell exosome-like vesicles. In this
regard, nidogen-1 and agrin were only recently identified in
exosome-like vesicles [37] and join type IV collagen, laminin, and
fibulin-1 as basement membrane matrix proteins present in
exosome-like vesicles. The presence of Fibronectin, C3 and
TGFb-ih3 was confirmed by Western blot (Figures S2 and S3).
A search of the database STRING disclosed relationships between
OPG and proteins identified in tubular cell-derived exosomal-like
vesicles by LC-MS/MS (Figure 3).
Exosome-like Vesicles are Present in Human Urine and
Contain OPG
The next step was to assess whether OPG was present in
exosome-like vesicles from human urine samples. First we
confirmed by electron microscopy that the isolation protocol
applied to urine resulted in microvesicles with exosomal features in
size and shape (Figure 4A). We confirmed the presence in these
vesicles of the exosomal markers ALIX, CD63 and TSG101
(Figure 4B). As it was the case for exosome-like vesicles derived
from human proximal tubular cells, human urine exosome-like
vesicles contained OPG as assessed by Western blot (Figure 4B)
and ELISA (352861994 pg OPG/m g exosomal protein, not
shown).
OPG Expression is Increased in Exosome-like Vesicles
from CKD Urine
An exploratory study in urine from healthy controls or CKD
patients (Table 1) disclosed that urinary exosome-like vesicle
protein content was higher in urine from CKD patients than in
non-CKD controls (Figure 5A). OPG-containing exosome-like
vesicles were detected in human urine samples, as assessed by
Western blot, both in healthy volunteers and in CKD patients.
Figure 6. OPG immunohistochemistry in human kidneys. Control, CKD and autosomal dominant polycystic kidney disease kidneys samples
were studied. For ADPKD a cortical cyst wall is shown. A) OPG mainly stained the basolateral aspect of proximal tubules in control kidneys
(arrowheads). B) In CKD whole tubular cells are intensely stained in the cortex (arrows). C) A similar pattern of intense whole cell staining is observed
in cyst epithelial lining (arrows). Original magnification6200.
doi:10.1371/journal.pone.0072387.g006
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Since in a preliminary analysis the highest OPG content
corresponded to patients with ADPKD, further studies were
performed in this population. OPG is higher in exosome-like
vesicles obtained from ADPKD CKD patients than from healthy
controls (Figure 5B). Increased levels were also found in diabetic
nephropathy (n = 3, 5.8760.28 Arbitrary Density Units, A.D.U.),
IgA nephropathy (n = 1, 18.78 A.D.U) and CAKUT (Congenital
anomalies of the kidney and urinary tract) (n = 1, 22.58 A.D.U)(-
Figure S4).
Increased OPG mRNA had been observed in the transcriptome
from human DN biopsies [16]. However results from urinary
exosome-like vesicles suggested that other nephropathies might be
associated to increased kidney OPG. A search of the Nephromine
database of published kidney transcriptome datasets disclosed that
OPG mRNA was increased in the tubulointerstitium of a different
DN data set (fold-change vs control: 2.4, p = 4.83E-4) as well as in
IgA nephropathy (fold-change vs control: 1.7, p = 2.07E-4)
[34,38,39,40]. Furthermore renal cortex OPG gene expression
correlated with chronicity index quartile (correlation: 0.497,
p = 3.60E-5) in aging humans [34,40]. OPG immunohistochem-
istry of human kidneys showed that OPG is mainly expressed in
the basolateral aspect of proximal tubules in control kidneys
(Figure 6). In CKD whole tubular cells are intensely stained in the
cortex. A similar pattern of intense whole cell staining is observed
in cyst epithelial lining in ADPKD.
Discussion
Exosomes are secreted by most cell types and are also found in
most biological fluids. Thus, tubular cells are expected to secrete
exosomes and exosomes are found in the urine. However, there
was no information on proximal tubular cell exosomes. We have
shown for the first time that cultured human proximal tubular
epithelial cells constitutively secrete exosome-like vesicles that
contain the decoy receptor OPG as well as several other proteins,
some not previously known to be exosomal proteins. The
difference between various types of secreted microvesicles has
generated a controversy in recent years and is not fully solved.
Microvesicles isolated from tubular cell supernatants and from
urine shared several exosomal characteristics, including their
membrane-bound nature, the 50–100 nm size and the presence of
exosomal markers such as CD63, TSG101, Calnexin and ALIX.
However, increasing evidence has undermined the specificity of
exosome markers and we cannot rule out that non-exosomal
microvesicles are secreted by tubular cells and found in urine [41].
Although CD63 is much more abundant in late endosomes and
lysosomes it is also expressed on cell surface [42] and nanotubes
[43]. TSG101 is found in arrestin domain-containing protein 1-
mediated microvesicles (ARMMs) [44] [45] and its role as a
Endosomal Sorting Complexes Required for Transport (ESCRT)
protein is far from being completely understood. The main
functional family represented in proximal tubular cell exosome-
like vesicles was the extracellular matrix, which points to a
function of exosome-like vesicles in the modulation of cell-matrix
interactions, normal matrix turnover or fibrosis. Furthermore,
exosome-like vesicles containing OPG were found in urine from
CKD patients and kidney OPG mRNA and protein is increased in
diverse nephropathies and protein localized to tubular cells.
The function of exosomes is incompletely understood. Exo-
somes were first described as part of the cell protein recycling
machinery and thought to function in the disposal of unwanted
material [3,46]. More recently their involvement in normal and
abnormal intercellular communication has been emphasized. In
this regard, exosomes contain mRNA and small RNAs, proteins
and lipids [47]. One of the functions of exosomes is regulation of
cell death. There is evidence supporting a role of cell death by
apoptosis in the gradual loss of renal mass in CKD [15,48]. T cell-
derived exosomes are loaded with lethal TNF superfamily
cytokines that increase their killing capacity both by providing
simultaneously several lethal stimuli and by providing them on a
surface rather than soluble [36,49]. Conversely, TNF superfamily
receptors in microvesicles may behave as decoys, dampening the
response to TNF superfamily cytokines. Thus, microvesicles may
contain TNF-R1 [13]. Our studies disclosed that TRAIL is not
found in tubular cell exosome-like vesicles, unlike in exosomes
from T cells. However, there is functional evidence that tubular
cells are sensitive to TRAIL-induced death, at least under certain
environmental conditions [16]. In this regard, TRAIL and OPG
are the most overexpressed apoptosis-related genes in the most
frequent cause of CKD, DN. OPG is a decoy receptor for TRAIL
that is expressed by proximal tubular cells [19] [16,50]. OPG
expression by tubular cells protects them from TRAIL induced-
apoptosis as evidenced by the increased rate of apoptosis when a
specific antibody in tubular cells neutralized endogenous OPG
[16]. The presence of OPG in tubular cell and urinary exosomes
suggests that tubular cells may regulate different aspects of TRAIL
and RANKL biology by secreting OPG in exosomes. We
uncovered evidence in transcriptomics databases that suggests
that increase kidney tubulointerstitial expression of OPG is found
in diverse causes of CKD, including DN, glomerulonephritis and
aging. OPG expression was localized to tubular cells in control and
diseased kidneys by immunohistochemistry albeit the pattern of
expression differed: luminal OPG expression was more prominent
in CKD tubules and in cells lining ADPKD cysts. This location of
OPG may contribute to OPG presence in urinary exosomes and,
we speculate, even in kidney cyst fluid. The presence of OPG in
exosomes may also be involved in the regulation of vascular
calcification. Microvesicles are important in the calcification
process and OPG has an anti-calcification role [20]. Fetuin,
another factor that prevents vascular calcification, was recently
reported to be present in kidney-derived exosomes [5]. The
presence of OPG in circulating microvesicles should be explored
since plasma OPG is associated with increased cardiovascular risk
[51,52].
While extracellular matrix proteins have long popped up in lists
of exosomal proteins [37,53], there is an insufficient understanding
of the role of exosomes in the regulation of cell-matrix interactions,
normal extracellular matrix deposition or fibrosis. Vesicle inter-
action with collagen types II and X is necessary for optimal bone
calcification [54]. Exosomes derived from fibroblasts contain type
I collagen [55]. Matrix metalloproteinases are also components of
exosomes [56]. More recently exosomes derived from human
umbilical cord mesenchymal stem cells were shown to regulate
fibrosis in vivo [57]. In exosomes from proximal tubular epithelial
cells a proteomics approach disclosed a striking presence of
extracellular matrix proteins. Consistent with our understanding of
tubular cell biology [58] several of these extracellular matrix
proteins are known components of basement membranes,
including two chains of type IV collagen (a1 and a2), laminin,
nidogen-1, agrin and fibulin-1. However, there are no prior
reports of such concentration of basement membrane proteins in
exosomes from a particular cell type. This overrepresentation of
extracellular matrix protein merits further functional studies under
basal or stressed conditions in cultured cells as well as an
exploration of their potential role as biomarkers in the clinical
setting. Potential interactions between OPG and other proteins
found in tubular cell-derived exosome-like vesicles were explored
by database searches (KUPKB, STRING) and manual Pubmed
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searches. Complement 3 is involved in osteoclast formation in
which OPG plays a role, but a direct interaction had not been
described. OPG increases the arterial expression of TGF-b1 and
promotes TGF-b1, fibronectin and collagen type IV expression in
vascular smooth muscle cells [59]. Furthermore, TGF-b1
promoted the expression/release of endogenous OPG from
vascular smooth muscle cells. OPG binds with high avidity to
thrombospondin (TSP-1) [60]. In this regard, our studies do not
address how is OPG linked to exosomes. One possibility is that
OPG interacts with other membrane-bound proteins or proteo-
glycans, including thrombospondin-1. CYR61 has a role in
proliferation and angiogenesis and is co-upregulated with OPG
in an inflammatory osteocyte model [61]. As described in the
UniProt KB database, some of the identified proteins are
basement membrane related, including Col4A2, nidogen 1,
laminin subunit alpha-5 and agrin. Agrin is preferentially
expressed in kidney and lung [62].
The diagnostic potential of urinary exosomes is under
evaluation [63]. Analysis of urinary exosomes may provide a
non-invasive insight into events taking place in the kidney. Altered
exosomal expression of aquaporins 1 and 2 has been reported in
renal ischemia/reperfusion and antidiuretic hormone action [64].
Here we describe an increased amount of exosomal protein in the
urine of CKD patients. This suggests that the CKD environment
may regulate the secretion of exosomes, although the factors that
may contribute to this observation are yet uncharacterized.
Furthermore, we describe for the first time the presence of OPG
in urinary exosomes, and its increased expression in patients with
CKD. More specifically, we observed increased urinary exosome
OPG in ADPKD patients and the presence of OPG in cells lining
the cysts. OPG was also found on the luminal side on non-cystic
CKD tubules. In ADPKD cyst formation starts during renal
development [65], [66] and progresses continuously in adulthood.
PKD protein-positive exosomes have been characterized, [67]
showing that some key proteins are shed in membrane particles in
the urine. Altered tubular cell proliferation and apoptosis as well as
abnormal deposition of extracellular matrix contribute to
cystogenesis in PKD [68,69] [70,71]. An overall predominance
of proliferation leads to the increased numbers of tubular cells that
line the cysts. Considering the role of OPG in other systems to
counterbalance the apoptotic effects of TRAIL, further investiga-
tions may focus on the hypothetical apoptotic-regulatory role of
OPG in PKD.
The clinical data should be considered as preliminary and
hypothesis-generating, as the study is limited by a small number of
patients. However, it clearly shows that urinary exosome-like
vesicles OPG can be assessed in the urine of CKD patients and a
cohort study in underway in order to address whether urinary
exosome-like vesicle OPG provides prognostic information on the
progression and outcome of CKD.
In summary, we have characterized for the first time proteins
present in human proximal tubular cell exosomes. The description
of exosomal OPG is novel and points to a role of tubular cell
exosomes in the regulation of cell death or inflammatory processes.
In addition, the high presence of extracellular matrix proteins
suggests a role of tubular cell exosomes in regulation extracellular
matrix deposition or cell-matrix interactions under physiological
or disease conditions. Further characterization of the function of
exosomal OPG and its biomarker potential should be pursued.
Supporting Information
Figure S1 SRM of additional OPG peptides. In addition to
the peptide shown in figure 2.D, three additional peptides and
their transitions had been monitored. Each depicted window
(including 2 or more chromatograms) shows different transitions
(fragments) from the same precursor. The peptides monitored
were A) GNATHDNICSGNSESTQK; B) SCPPGFGVVQAGT-
PER and C) CPPGTYLK.
(TIF)
Figure S2 Western blot confirmation of the presence in
proximal tubular cell derived exosomal-like vesicles of
representative proteins found in these vesicles by LC
MS/MS proteomics: Representative Western blot for Fibro-
nectin. Lanes contains 10 mg protein obtained from HK2 and
10 ug of tubular cell-derived exosome-like vesicles (ELV).
(TIF)
Figure S3 Western blot confirmation of the presence in
proximal tubular cell derived exosomal-like vesicles of
representative proteins found in these vesicles by LC
MS/MS proteomics. Representative Western blot for TGFb-
ih3 and C3. Five micrograms (5 mg) of proximal tubular cell
exosome-like vesicles protein were loaded in each lane.
(TIF)
Figure S4 OPG in human urinary exosomes. Representa-
tive Western blot. 5 mg urinary exosome-like vesicles protein were
loaded. DN: Diabetic Nephropathy; GN: Glomerulo Nephritis;
ADPKD: autosomal dominant polycystic kidney disease; CA-
KUT: Congenital anomalies of the kidney and urinary tract.
(TIF)
Table S1 Proteins identified in tubular epithelial cell-
derived exosomes by SDS-PAGE and LC-MS/MS analy-
sis. The sequences presented in Italic grey are repeated
sequences. Con: Confidence; %Cov: Coverage Percentage. Prec
MW: precursor Molecular Weight; Theor MW: Theoretical
Molecular Weight.
(XLS)
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